ggwpq, if true, that the Prima facie-rebuttal approach has the effect of weakening the "Clear and Overwhelming evidence" standard, the implications would be desasterous for drug innovation. It may be usesful in fields that do not require trials as their centerpiece for validation.
Market Data 
Markets 
AI
